DWS Health and Wellness C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
DWS Health and Wellness Fund - Class C SUHCX
- NAV / 1-Day Return 21.45 / +1.40 %
- Total Assets 233.3M
-
Adj. Expense Ratio
2.080%
- Expense Ratio 2.100%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Health
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 1%
USD | NAV as of Jun 09, 2026 | 1-Day Return as of Jun 09, 2026, 9:22 PM GMT+0
Morningstar’s Analysis SUHCX
Will SUHCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the SUHCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of SUHCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.64 | 29M | Healthcare |
Johnson & Johnson | 6.35 | 15M | Healthcare |
UnitedHealth Group Inc | 6.15 | 14M | Healthcare |
AbbVie Inc | 4.79 | 11M | Healthcare |
Merck & Co Inc | 4.49 | 10M | Healthcare |
AstraZeneca PLC | 3.86 | 9M | Healthcare |
Thermo Fisher Scientific Inc | 3.39 | 8M | Healthcare |
Amgen Inc | 2.98 | 7M | Healthcare |
Intuitive Surgical Inc | 2.91 | 7M | Healthcare |
Novartis AG ADR | 2.87 | 7M | Healthcare |
United States